The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Peritoneal Dialysis, Continuous Ambulatory

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Peritoneal Dialysis, Continuous Ambulatory


Psychiatry related information on Peritoneal Dialysis, Continuous Ambulatory


High impact information on Peritoneal Dialysis, Continuous Ambulatory


Chemical compound and disease context of Peritoneal Dialysis, Continuous Ambulatory


Biological context of Peritoneal Dialysis, Continuous Ambulatory


Anatomical context of Peritoneal Dialysis, Continuous Ambulatory


Associations of Peritoneal Dialysis, Continuous Ambulatory with chemical compounds


Gene context of Peritoneal Dialysis, Continuous Ambulatory


Analytical, diagnostic and therapeutic context of Peritoneal Dialysis, Continuous Ambulatory


  1. Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis. Dieplinger, H., Schoenfeld, P.Y., Fielding, C.J. J. Clin. Invest. (1986) [Pubmed]
  2. Peritonitis in continuous ambulatory peritoneal dialysis. Laboratory and clinical studies. Gokal, R., Ramos, J.M., Francis, D.M., Ferner, R.E., Goodship, T.H., Proud, G., Bint, A.J., Ward, M.K., Kerr, D.N. Lancet (1982) [Pubmed]
  3. Longitudinal lipid profiles on CAPD: their relationship to weight gain, comorbidity, and dialysis factors. Little, J., Phillips, L., Russell, L., Griffiths, A., Russell, G.I., Davies, S.J. J. Am. Soc. Nephrol. (1998) [Pubmed]
  4. Hypercalcemia during pulse vitamin D3 therapy in CAPD patients treated with low calcium dialysate: the role of the decreasing serum parathyroid hormone level. Chagnac, A., Ori, Y., Weinstein, T., Zevin, D., Korzets, A., Hirsh, J., Edelstein, S., Gafter, U. J. Am. Soc. Nephrol. (1997) [Pubmed]
  5. Effects of insulin and amino acids on glucose and leucine metabolism in CAPD patients. Castellino, P., Luzi, L., Giordano, M., Defronzo, R.A. J. Am. Soc. Nephrol. (1999) [Pubmed]
  6. Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Türk, S., Karalezli, G., Tonbul, H.Z., Yildiz, M., Altintepe, L., Yildiz, A., Yeksan, M. Nephrol. Dial. Transplant. (2001) [Pubmed]
  7. Peritoneal dialysis prescription: the "Clearance Peak" model. Virga, G., Amici, G., Da Rin, G. The International journal of artificial organs. (1994) [Pubmed]
  8. Practice and list effects on the synthetic sentence identification test in young and elderly listeners. Feeney, M.P., Hallowell, B. J. Speech Lang. Hear. Res. (2000) [Pubmed]
  9. CAPD with dialysis solution containing glucose polymer. Martis, L., Shockley, T., Henderson, L. Lancet (1993) [Pubmed]
  10. Short-course gentamicin in gram-negative CAPD peritonitis. Dryden, M., Eykyn, S.J. Lancet (1993) [Pubmed]
  11. Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Macdougall, I.C., Roberts, D.E., Neubert, P., Dharmasena, A.D., Coles, G.A., Williams, J.D. Lancet (1989) [Pubmed]
  12. Gastric emptying of an indigestible solid in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis. Brown-Cartwright, D., Smith, H.J., Feldman, M. Gastroenterology (1988) [Pubmed]
  13. Aztreonam in CAPD peritonitis. Dratwa, M., Glupczynski, Y., Lameire, N., Matthys, D., Verschraegen, G., van Eeckhoute, M., Boelaert, J., Schurgers, M., van Landuyt, H., Verbeelen, D. Lancet (1987) [Pubmed]
  14. Oral ciprofloxacin for the first-phase treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. Zacherle, B.J. J. Am. Soc. Nephrol. (1996) [Pubmed]
  15. Intraleukocytic sequestration as a cause of persistent Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis. Buggy, B.P., Schaberg, D.R., Swartz, R.D. Am. J. Med. (1984) [Pubmed]
  16. Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent. Levine, J., Bernard, D.B., Idelson, B.A., Farnham, H., Saunders, C., Sugar, A.M. Am. J. Med. (1989) [Pubmed]
  17. Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients. Low, C.L., Gopalakrishna, K., Lye, W.C. J. Am. Soc. Nephrol. (2000) [Pubmed]
  18. Radioiodine dosimetry in patients with end-stage renal disease receiving continuous ambulatory peritoneal dialysis therapy. Kaptein, E.M., Levenson, H., Siegel, M.E., Gadallah, M., Akmal, M. J. Clin. Endocrinol. Metab. (2000) [Pubmed]
  19. Clinical outcome of continuous ambulatory peritoneal dialysis predicted by urea and creatinine kinetics. Brandes, J.C., Piering, W.F., Beres, J.A., Blumenthal, S.S., Fritsche, C. J. Am. Soc. Nephrol. (1992) [Pubmed]
  20. Hemodialysis and continuous ambulatory peritoneal dialysis effects on erythropoiesis in renal failure. McGonigle, R.J., Husserl, F., Wallin, J.D., Fisher, J.W. Kidney Int. (1984) [Pubmed]
  21. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Salusky, I.B., Ramirez, J.A., Oppenheim, W., Gales, B., Segre, G.V., Goodman, W.G. Kidney Int. (1994) [Pubmed]
  22. Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy. Małyszko, J., Małyszko, J.S., Hryszko, T., Myśliwiec, M. Thromb. Haemost. (2004) [Pubmed]
  23. Randomized long-term evaluation of bicarbonate-buffered CAPD solution. Feriani, M., Kirchgessner, J., La Greca, G., Passlick-Deetjen, J. Kidney Int. (1998) [Pubmed]
  24. Elevated superoxide generation in mononuclear phagocytes by treatment with 1 alpha hydroxyvitamin D3: changes in kinetics and in oxidase cytosolic factor p47. Deutsch, A., Chaimovitzch, C., Nagauker-Shriker, O., Zlotnik, M., Shany, S., Levy, R. J. Am. Soc. Nephrol. (1995) [Pubmed]
  25. Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane. Mortier, S., De Vriese, A.S., McLoughlin, R.M., Topley, N., Schaub, T.P., Passlick-Deetjen, J., Lameire, N.H. J. Am. Soc. Nephrol. (2003) [Pubmed]
  26. Antioxidant enzymes and lipoperoxide in blood in uremic children and adolescents. Asayama, K., Shiki, Y., Ito, H., Hasegawa, O., Miyao, A., Hayashibe, H., Dobashi, K., Kato, K. Free Radic. Biol. Med. (1990) [Pubmed]
  27. Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis. Somani, P., Shapiro, R.S., Stockard, H., Higgins, J.T. Clin. Pharmacol. Ther. (1982) [Pubmed]
  28. Free and esterified carnitine in continuous ambulatory peritoneal dialysis patients. Constantin-Teodosiu, D., Kirby, D.P., Short, A.H., Burden, R.P., Morgan, A.G., Greenhaff, P.L. Kidney Int. (1996) [Pubmed]
  29. Vitamin K2 and serum cholesterol in patients on continuous ambulatory peritoneal dialysis. Nagasawa, Y., Fujii, M., Kajimoto, Y., Imai, E., Hori, M. Lancet (1998) [Pubmed]
  30. Carnitine status of continuous ambulatory peritoneal dialysis patients. Albright, R.K., Kram, B.W., White, R.P. Lancet (1982) [Pubmed]
  31. Acute aluminium intoxication in patients on continuous ambulatory peritoneal dialysis. Cumming, A.D., Simpson, G., Bell, D., Cowie, J., Winney, R.J. Lancet (1982) [Pubmed]
  32. Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Maiorca, R., Cantaluppi, A., Cancarini, G.C., Scalamogna, A., Broccoli, R., Graziani, G., Brasa, S., Ponticelli, C. Lancet (1983) [Pubmed]
  33. Can an excess of estimated over-predicted creatinine generation be a discriminating test for noncompliance in continuous ambulatory peritoneal dialysis? Tzamaloukas, A.H. J. Am. Soc. Nephrol. (1995) [Pubmed]
  34. Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients. Malyszko, J., Malyszko, J.S., Brzosko, S., Wolczynski, S., Mysliwiec, M. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  35. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Pereira, B.J., Shapiro, L., King, A.J., Falagas, M.E., Strom, J.A., Dinarello, C.A. Kidney Int. (1994) [Pubmed]
  36. In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD. Pereira, B.J., Poutsiaka, D.D., King, A.J., Strom, J.A., Narayan, G., Levey, A.S., Dinarello, C.A. Kidney Int. (1992) [Pubmed]
  37. Zinc modulates mononuclear cellular calcitriol metabolism in peritoneal dialysis patients. Kimmel, P.L., Phillips, T.M., Lew, S.Q., Langman, C.B. Kidney Int. (1996) [Pubmed]
  38. Effects of acetate dialysate on transforming growth factor beta 1, interleukin, and beta 2-microglobulin plasma levels. Anderson, J., Briefel, G., Jones, J.M., Ryu, J.H., McGuire, M., Yun, Y.P. Kidney Int. (1991) [Pubmed]
  39. Glucose polymer for ultrafiltration failure in CAPD. Stein, A., Peers, E., Harris, K., Feehally, J., Walls, J. Lancet (1993) [Pubmed]
  40. Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal. Costello, J.F., Sadovnic, M.J., Cottington, E.M. J. Am. Soc. Nephrol. (1991) [Pubmed]
  41. Lack of plasma interleukin-1 beta or tumor necrosis factor-alpha elevation during unfavorable hemodialysis conditions. Powell, A.C., Bland, L.E., Oettinger, C.W., McAllister, S.K., Oliver, J.C., Arduino, M.J., Favero, M.S. J. Am. Soc. Nephrol. (1991) [Pubmed]
WikiGenes - Universities